STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
J
Active, not recruiting
- Leukemia, Lymphocytic, Chronic, B-Cell
- Lymphoma, Mantle-Cell
- Paris Cedex 13, France(unnamed)
2022-03-24
Mar 24, 2022S
Not yet recruiting
- Leukemia, Lymphocytic, Chronic, B-Cell
- JWCAR029 (Relmacabtagene Autoleucel)
- Nanjing, Jiangsu, ChinaJiangsu Province Hospital
2022-02-17
Feb 17, 2022M
Recruiting
- Lymphoma, Non-Hodgkin
- +4 more
- Rochester, MinnesotaMayo Clinic
2021-08-30
Aug 30, 2021U
Recruiting
- Leukemia, Lymphocytic, Chronic, B-Cell
- Abnormalities Cell Epithelial
- Zurich, SwitzerlandUniversity Hospital Zurich
2021-10-05
Oct 5, 2021C
Recruiting
- Leukemia
- +3 more
- CD19 CAR-T cells
- Chongqing, Chongqing, ChinaChongqing University Cancer Hospital
2021-03-01
Mar 1, 2021H
Completed
- B-cell Leukemia
- CD19/CD20 Dual-CAR-T cells
- Sanhe, Hebei, ChinaHebei Yanda Ludaopei Hospital
2022-03-06
Mar 6, 2022C
Recruiting
- Leukemia
- +4 more
- CD19 CAR-T cells
- Kunming, Yunnan, China920th Hospital of Joint Logistics Support Force
2021-03-01
Mar 1, 2021U
Not yet recruiting
- Chronic Lymphocytic Leukemia
- [U-13C]glucose
- [13C5]glutamine
- (no location specified)
2022-03-18
Mar 18, 2022A
Completed
- Leukemia, Lymphocytic, Chronic, B-Cell
- Innsbruck, Tirol, Austria
- +6 more
2022-02-15
Feb 15, 2022T
Completed
- CLL
- Tampere, FinlandTampere university Hospital
2022-02-22
Feb 22, 2022D
Recruiting
- Chronic Lymphocytic Leukemia
- Boston, MassachusettsDana Farber Cancer Institute
2021-07-14
Jul 14, 2021N
Recruiting
- Chronic Lymphocytic Leukemia
- Taipei, TaiwanNational Taiwan University Hospital
2021-10-27
Oct 27, 2021N
Completed
- Chronic Lymphocytic Leukemia (CLL)
- (no location specified)
2022-04-05
Apr 5, 2022L
Not yet recruiting
- Chronic Lymphocytic Leukemia
- +3 more
- (no location specified)
2022-02-15
Feb 15, 2022U
Completed
- B-cell Leukemia
- B-Cell Lymphoma
- CAR T cells
- Uppsala, SwedenUppsala University Hospital, Dept of Oncology
2021-10-14
Oct 14, 2021M
Not yet recruiting
- B-cell Non Hodgkin Lymphoma
- B-cell Chronic Lymphocytic Leukemia
- Dose Level -1: 0.75x10^6 cells/kg CAR20.19.22 cells
- +3 more
- Milwaukee, WisconsinMedical College of Wisconsin and Froedtert Hospital
2022-03-30
Mar 30, 2022N
Terminated
- Small Lymphocytic Leukemia (SLL)
- Chronic Lymphocytic Leukemia (CLL)
- Bethesda, MarylandNational Institutes of Health Clinical Center
2022-02-15
Feb 15, 2022N
Completed
- Chronic Lymphocytic Leukemia
- Manhasset, New YorkFeinstein Institute for Medical Research
2021-03-02
Mar 2, 2021W
Active, not recruiting
- Leukemia
- Lymphoma
- ET019003-T Cells
- Wuhan, Hubei, ChinaUnion Hospital, Tongji Medical College, Huazhong University of S
2021-11-11
Nov 11, 2021A
Not yet recruiting
- B Cell Leukemia
- Lymphoma
- SNP analysis of the DNA
- (no location specified)
2021-10-26
Oct 26, 2021M
Completed
- CLL
- Leukemia
- Houston, TexasUniversity of Texas MD Anderson Cancer Center
2022-03-14
Mar 14, 2022U
Recruiting
- Chronic Lymphoid Leukemia in Relapse
- Belimumab 200 MG/ML [Benlysta]
- standard of care
- Tuebingen, BW, GermanyUniversity Hospital Tuebingen, CCU Translational Immunology
2022-02-02
Feb 2, 2022E
Recruiting
- Leukemia, Lymphocytic, Chronic, B-Cell
- +6 more
- Miami, Florida
- +4 more
2022-03-07
Mar 7, 2022M
Active, not recruiting
- Chronic Lymphocytic Leukemia
- Questionnaire Administration
- Ruxolitinib Phosphate
- Houston, TexasM D Anderson Cancer Center
2022-02-02
Feb 2, 2022E
Active, not recruiting
- Neoplasms
- +5 more
- Intermittent fast
- Victoria, British Columbia, CanadaEleah Stringer
2022-03-15
Mar 15, 2022